Tuesday, November 12, 2024
HomeCall for ApplicationsMicrosoft GenAI Accelerator Program for AI start-ups in UK.

Microsoft GenAI Accelerator Program for AI start-ups in UK.

Application Deadline: 22 November 2024

Applications are now open for the 2024 Microsoft GenAI Accelerator Program. In partnership with tech leader NVIDIA and Microsoft-owned developer platform GitHub, the Microsoft GenAI Accelerator will provide exclusive resources and opportunities to companies looking to build, market, and scale up their generative AI products and services.

The Accelerator, which will run from January 2025 to early March 2025, is specifically tailored for UK AI start-ups that have secured seed funding and are looking to take their products to the next level.

Microsoft is seeking companies whose innovative AI-powered products have the potential to change people’s lives for the better, create jobs, and have significant economic impact.

A hybrid format – part online, part in person – will ensure that geographical boundaries do not hinder participation, enabling a diverse range of companies – not just those based in London and the South East – to benefit from the resources and support on offer.

Requirements

  • UK-based AI start-ups and scale-ups which already have a product in the market and are innovating across various sectors, including Fintech, Medtech, and Greentech.
  • Microsoft is particularly encourage companies that are looking to build AI-native solutions on Microsoft’s cloud to apply.

Benefits

  • Participants will receive one-to-one support from Microsoft’s AI ‘Black Belt’ team – specialists in AI and machine learning – as well as access to workshops and help provided by partners NVIDIA and GitHub.

Application Timeline:

  • Launch Date: 4 November 2024
  • Application Period: 4 November 2024 to 22 November 2024
  • Shortlisting: week commencing 9 December 2024.
  • Programme Duration: 22 January 2025 to 5 March 2025
  • Demo Day: Early March 2025

More Info: Microsoft GenAI Accelerator Program

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular